This report analyzes the worldwide markets for Pulmonary Drug Delivery Technologies in Millions of US$. The specific product segments analyzed are Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), and Nebulizers. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 55 companies including many key and niche players worldwide such as 3M Drug Delivery Systems Division, Akela Pharma Inc., Alkermes Inc., Aradigm Corporation, AstraZeneca Plc, Baxter Healthcare Corporation, Chiesi Farmaceutici SpA, Consort Medical Plc, Dey L.P., GlaxoSmithKline Plc, Graceway Pharmaceuticals, LLC, Nektar Therapeutics, Oriel Therapeutics Inc., Sepracor Inc., SkyePharma Plc, and Vectura Group Plc . Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.
Adobe Acrobat Reader 7.0 is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.
Titles available via "online download" are not affected by this and are still delivered to your reading room immediately.
Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.
(0 items)
